Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following γ-irradiation

Oncogene

Volumn 15, Issue 15, 1997, Pages 1815-1822

  Milner, Anne E ^a   Grand, Roger J A ^a   Vaughan, Andrew T M ^c   Armitage, Richard J ^b   Gregory, Christopher D ^a,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b AMGEN INC   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Burkitt lymphoma; CD40; Cell cycle; irradiation

Indexed keywords

CD40 ANTIGEN; MUTANT PROTEIN; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MITOSIS INHIBITION; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0030725679     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201355     Document Type: Article

References (46)

1. Bates S and Vousden KH. (1996). Curr. Opin. Genet. Dev., 6, 12-18.
2. Borner C. (1996). J. Biol. Chem., 271, 12695-12698.
3. Bracey TS, Miller JC, Preece A and Paraskeva C. (1995). Oncogene, 10, 2391-2396.
4. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP and Guyotat D. (1993). Blood, 81, 3091-3096.
5. Canman CE, Gilmer TM, Coutts SB and Kastan MB. (1995). Genes & Dev., 9, 600-611.
6. Collins MKL, Marvel J, Malde P and Lopez-Rivas A. (1992). J. Exper. Med., 176, 1043-1051.
7. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE and Wyllie AH. (1992). Biochimica Et Biophysica Acta, 1133, 275-285.
8. Gilbert MS, Rupnow BA, Ramirez DA, Trister KD and Knox SJ. (1996). Cell Death Different., 3, 215-222.
9. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J and Rickinson AB. (1991). Nature, 349, 612-614.
10. Gregory CD, Rowe M and Riekinson AB. (1990). J. Gen. Virol., 71, 1481-1495.
11. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A. (1991). Cell, 65, 1107-1115.
12. Herod JJO, Eliopoulos AG, Warwick J, Niedobitek G, Young LS and Kerr DJ. (1996). Cancer Res., 56, 2178-2184.
13. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD and Gordon J. (1993). Euro. J. Immunol., 23, 2368-2371.
14. Ishida T, Kobayashi N, Tojo T, Ishida S, Yamamoto T and Inoue J. (1995). J. Immunol., 155, 5527-5535.
15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
16. Kastan MB, Zhan QM, Eldeiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. (1992). Cell, 71, 587-597.
17. Kruman II, Matylevich NP, Beletsky IP, Afanasyev VN and Umansky SR. (1991). J. Cell. Physiol., 148, 267-273.
18. Kyprianou N, King ED, Bradbury D and Rhee JG. (1997). Inter. J. Cancer, 70, 341-348.
19. Lepelley P, Soenen V, Preudhomme C, Merlat A, Cosson A and Fenaux P. (1995). Leukemia, 9, 726-730.
20. Linette GP, Li Y, Roth K and Korsemeyer SJ. (1996). Proc. Natl. Acad. Sci., 93, 9545-9552.
21. Lock RB and Stribinskiene L. (1996). Cancer Res., 56, 4006-4012.
22. Marvel J, Perkins GR, Rivas AL and Collins MKL. (1994). Oncogene, 9, 1117-1122.
23. Mazel S, Burtrum D and Petrie HT. (1996). J. Exper. Med., 183, 2219-2226.
24. Michalovitz D, Halevy O and Oren M. (1990). Cell, 62, 671-680.
25. Milner AE, Grand RJA, Waters CM and Gregory CD. (1993). Oncogene, 8, 3385-3391.
26. Milner AE, Johnson GD and Gregory CD. (1992). Intern. J. Cancer, 52, 636-644.
27. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP and Korsmeyer SJ. (1990). J. Immunol., 144, 3602-3610.
28. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW. (1993). Cancer Res., 53, 4776-4780.
29. O'Reilly LA, Huang DCS and Strasser A. (1996). EMBO J., 15, 6979-6990.
30. Pezzella F, Jones M, Ralfkiaer E, Ersboll J, Gatter KC and Mason DY. (1992). Br. J. Cancer, 65, 87-89.
31. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 3714-3717.
32. Piris MA, Pezella F, Martinezmontero JC, Orradre JL, Villuendas R, Sanchezbeato M, Cuena R, Cruz, MA, Martinez B, Garrido MC, Gatter K, Aiello A, Delia D, Giardini R and Rilke F. (1994). Br. J. Cancer, 69, 337-341.
33. Radford IR. (1994). International Journal of Radiation Biology, 66, 557-560.
34. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H and Rickinson AB. (1987). EMBO J., 6, 2743-2751.
35. Sangfelt O, Einhorn S, Bjorklund AC, Wilman KG, Okan I and Grander D. (1996). Intern. J. Cancer, 67, 106-112.
36. Seki H, Iwai K, Kanegane H, Konno A, Ohta K, Ohta K, Yachie A, Taniguchi N and Miyawaki T. (1995). Cell. Immun., 163, 30-36.
37. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ. (1991). Cell, 67, 879-888.
38. Silvestrini R, Benini E, Veneroni S, Daidone MG, Tomasic G, Squicciarini P and Salvadori B. (1996). J. Clin. Oncol., 14, 1604-1610.
39. Soldatenkov VA, Notario V and Dritschilo A. (1996). Inter. J. Oncol., 9, 547-551.
40. Strasser A, Harris AW, Jacks T and Cory S. (1994). Cell, 79, 329-339.
41. Tewari M and Dixit VM. (1996). Curr. Opin. Genet. Dev., 6, 39-44.
42. Tjalma W, Weyler J, Goovaerts G, De Pooler C, Van Marck E and van Dam P. (1997). J. Clin. Path., 50, 33-36.
43. Walker A, Taylor ST, Hickman JA and Dive C. (1997). Cancer Res., 57, 1939-1945.
44. Wang H, Grand RJA, Milner AE, Armitage RJ, Gordon J and Gregory CD. (1996). Oncogene, 13, 373-379.
45. Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES and Raffeld M. (1997). Blood, 89, 601-609.
46. Yonish-Rouach E, Resnitzky D, Lotem J, Sacks L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.